nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—Developmental delay—Fluorouracil—pancreatic cancer	0.0162	0.0512	CcSEcCtD
Tiludronate—Congenital anomaly—Fluorouracil—pancreatic cancer	0.0162	0.0512	CcSEcCtD
Tiludronate—Bone pain—Tamoxifen—pancreatic cancer	0.00951	0.03	CcSEcCtD
Tiludronate—Bone pain—Erlotinib—pancreatic cancer	0.00941	0.0297	CcSEcCtD
Tiludronate—Influenza-like symptoms—Gemcitabine—pancreatic cancer	0.00877	0.0277	CcSEcCtD
Tiludronate—Bone pain—Sunitinib—pancreatic cancer	0.00815	0.0257	CcSEcCtD
Tiludronate—Influenza like illness—Sunitinib—pancreatic cancer	0.00758	0.0239	CcSEcCtD
Tiludronate—Bone pain—Gemcitabine—pancreatic cancer	0.00654	0.0206	CcSEcCtD
Tiludronate—Influenza like illness—Gemcitabine—pancreatic cancer	0.00608	0.0192	CcSEcCtD
Tiludronate—Bone pain—Docetaxel—pancreatic cancer	0.00464	0.0147	CcSEcCtD
Tiludronate—Influenza like illness—Docetaxel—pancreatic cancer	0.00432	0.0136	CcSEcCtD
Tiludronate—Back pain—Tamoxifen—pancreatic cancer	0.00385	0.0122	CcSEcCtD
Tiludronate—Back pain—Erlotinib—pancreatic cancer	0.00381	0.012	CcSEcCtD
Tiludronate—Arthralgia—Tamoxifen—pancreatic cancer	0.00339	0.0107	CcSEcCtD
Tiludronate—Myalgia—Tamoxifen—pancreatic cancer	0.00339	0.0107	CcSEcCtD
Tiludronate—Arthralgia—Erlotinib—pancreatic cancer	0.00335	0.0106	CcSEcCtD
Tiludronate—Myalgia—Erlotinib—pancreatic cancer	0.00335	0.0106	CcSEcCtD
Tiludronate—Back pain—Sunitinib—pancreatic cancer	0.0033	0.0104	CcSEcCtD
Tiludronate—Rhinitis—Irinotecan—pancreatic cancer	0.00324	0.0102	CcSEcCtD
Tiludronate—Rhinitis—Gemcitabine—pancreatic cancer	0.00315	0.00996	CcSEcCtD
Tiludronate—Bone pain—Epirubicin—pancreatic cancer	0.00313	0.00988	CcSEcCtD
Tiludronate—Rhinitis—Fluorouracil—pancreatic cancer	0.0031	0.00979	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00296	0.00935	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00293	0.00926	CcSEcCtD
Tiludronate—Influenza like illness—Epirubicin—pancreatic cancer	0.00291	0.00919	CcSEcCtD
Tiludronate—Myalgia—Sunitinib—pancreatic cancer	0.0029	0.00917	CcSEcCtD
Tiludronate—Arthralgia—Sunitinib—pancreatic cancer	0.0029	0.00917	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—pancreatic cancer	0.00289	0.00914	CcSEcCtD
Tiludronate—Dyspepsia—Tamoxifen—pancreatic cancer	0.00286	0.00904	CcSEcCtD
Tiludronate—Dyspepsia—Erlotinib—pancreatic cancer	0.00283	0.00894	CcSEcCtD
Tiludronate—Pain—Tamoxifen—pancreatic cancer	0.00278	0.00878	CcSEcCtD
Tiludronate—Pain—Erlotinib—pancreatic cancer	0.00275	0.00869	CcSEcCtD
Tiludronate—Back pain—Irinotecan—pancreatic cancer	0.00272	0.00859	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—pancreatic cancer	0.00269	0.00851	CcSEcCtD
Tiludronate—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00266	0.0084	CcSEcCtD
Tiludronate—Back pain—Gemcitabine—pancreatic cancer	0.00265	0.00836	CcSEcCtD
Tiludronate—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00263	0.00831	CcSEcCtD
Tiludronate—Abdominal pain—Tamoxifen—pancreatic cancer	0.00257	0.00812	CcSEcCtD
Tiludronate—Abdominal pain—Erlotinib—pancreatic cancer	0.00254	0.00803	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00254	0.00801	CcSEcCtD
Tiludronate—Vertigo—Irinotecan—pancreatic cancer	0.00252	0.00797	CcSEcCtD
Tiludronate—Dyspepsia—Sunitinib—pancreatic cancer	0.00245	0.00774	CcSEcCtD
Tiludronate—Pain—Sunitinib—pancreatic cancer	0.00238	0.00752	CcSEcCtD
Tiludronate—Asthenia—Tamoxifen—pancreatic cancer	0.00233	0.00737	CcSEcCtD
Tiludronate—Myalgia—Gemcitabine—pancreatic cancer	0.00233	0.00736	CcSEcCtD
Tiludronate—Arthralgia—Gemcitabine—pancreatic cancer	0.00233	0.00736	CcSEcCtD
Tiludronate—Asthenia—Erlotinib—pancreatic cancer	0.00231	0.00729	CcSEcCtD
Tiludronate—Myalgia—Fluorouracil—pancreatic cancer	0.00229	0.00724	CcSEcCtD
Tiludronate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00228	0.00719	CcSEcCtD
Tiludronate—Rhinitis—Docetaxel—pancreatic cancer	0.00224	0.00707	CcSEcCtD
Tiludronate—Diarrhoea—Tamoxifen—pancreatic cancer	0.00222	0.00703	CcSEcCtD
Tiludronate—Abdominal pain—Sunitinib—pancreatic cancer	0.0022	0.00695	CcSEcCtD
Tiludronate—Diarrhoea—Erlotinib—pancreatic cancer	0.0022	0.00695	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PIK3CA—pancreatic cancer	0.00218	0.00319	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PTEN—pancreatic cancer	0.00216	0.00317	CbGpPWpGaD
Tiludronate—Dizziness—Tamoxifen—pancreatic cancer	0.00215	0.00679	CcSEcCtD
Tiludronate—Dizziness—Erlotinib—pancreatic cancer	0.00213	0.00672	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—HRAS—pancreatic cancer	0.00213	0.00311	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.0021	0.00307	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.00207	0.00303	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRSS1—pancreatic cancer	0.00206	0.00301	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ZNRF3—pancreatic cancer	0.00206	0.00301	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CB—pancreatic cancer	0.00206	0.00301	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—NRAS—pancreatic cancer	0.00205	0.003	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.00205	0.003	CbGpPWpGaD
Tiludronate—Headache—Tamoxifen—pancreatic cancer	0.00204	0.00643	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00204	0.00643	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—pancreatic cancer	0.00202	0.00295	CbGpPWpGaD
Tiludronate—Dyspepsia—Irinotecan—pancreatic cancer	0.00202	0.00638	CcSEcCtD
Tiludronate—Headache—Erlotinib—pancreatic cancer	0.00201	0.00636	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—SRC—pancreatic cancer	0.00201	0.00294	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.002	0.00632	CcSEcCtD
Tiludronate—Asthenia—Sunitinib—pancreatic cancer	0.002	0.00631	CcSEcCtD
Tiludronate—Pain—Irinotecan—pancreatic cancer	0.00196	0.00619	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—STAT3—pancreatic cancer	0.00194	0.00283	CbGpPWpGaD
Tiludronate—Dyspepsia—Fluorouracil—pancreatic cancer	0.00193	0.00611	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—NRAS—pancreatic cancer	0.00193	0.00283	CbGpPWpGaD
Tiludronate—Nausea—Tamoxifen—pancreatic cancer	0.00193	0.0061	CcSEcCtD
Tiludronate—Pain—Gemcitabine—pancreatic cancer	0.00191	0.00603	CcSEcCtD
Tiludronate—Nausea—Erlotinib—pancreatic cancer	0.00191	0.00603	CcSEcCtD
Tiludronate—Diarrhoea—Sunitinib—pancreatic cancer	0.0019	0.00602	CcSEcCtD
Tiludronate—Back pain—Docetaxel—pancreatic cancer	0.00188	0.00593	CcSEcCtD
Tiludronate—Pain—Fluorouracil—pancreatic cancer	0.00188	0.00593	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—AKT1—pancreatic cancer	0.00188	0.00275	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CD44—pancreatic cancer	0.00188	0.00275	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00188	0.00592	CcSEcCtD
Tiludronate—ATP6V1A—Disease—DTX1—pancreatic cancer	0.00186	0.00272	CbGpPWpGaD
Tiludronate—Dizziness—Sunitinib—pancreatic cancer	0.00184	0.00582	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.00182	0.00267	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IFNA1—pancreatic cancer	0.00182	0.00266	CbGpPWpGaD
Tiludronate—Abdominal pain—Irinotecan—pancreatic cancer	0.00181	0.00573	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—pancreatic cancer	0.0018	0.00263	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—pancreatic cancer	0.00178	0.00261	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PTEN—pancreatic cancer	0.00178	0.0026	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—pancreatic cancer	0.00176	0.00258	CbGpPWpGaD
Tiludronate—Headache—Sunitinib—pancreatic cancer	0.00174	0.00551	CcSEcCtD
Tiludronate—PTPN1—Immune System—IFNA5—pancreatic cancer	0.00174	0.00255	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IFNA2—pancreatic cancer	0.00169	0.00248	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—DTX4—pancreatic cancer	0.00169	0.00247	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—pancreatic cancer	0.00166	0.00243	CbGpPWpGaD
Tiludronate—Arthralgia—Docetaxel—pancreatic cancer	0.00165	0.00522	CcSEcCtD
Tiludronate—Myalgia—Docetaxel—pancreatic cancer	0.00165	0.00522	CcSEcCtD
Tiludronate—Nausea—Sunitinib—pancreatic cancer	0.00165	0.00522	CcSEcCtD
Tiludronate—Asthenia—Irinotecan—pancreatic cancer	0.00165	0.0052	CcSEcCtD
Tiludronate—PTPN1—Immune System—PPP2R5B—pancreatic cancer	0.00164	0.0024	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—pancreatic cancer	0.00162	0.00237	CbGpPWpGaD
Tiludronate—Asthenia—Gemcitabine—pancreatic cancer	0.0016	0.00506	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.00159	0.00232	CbGpPWpGaD
Tiludronate—Diarrhoea—Irinotecan—pancreatic cancer	0.00157	0.00496	CcSEcCtD
Tiludronate—ATP6V1A—Disease—DTX4—pancreatic cancer	0.00156	0.00228	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRLHR—pancreatic cancer	0.00153	0.00224	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRLHR—pancreatic cancer	0.00153	0.00224	CbGpPWpGaD
Tiludronate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00153	0.00483	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PIK3CA—pancreatic cancer	0.00153	0.00223	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PPP2R5B—pancreatic cancer	0.00152	0.00222	CbGpPWpGaD
Tiludronate—Dizziness—Irinotecan—pancreatic cancer	0.00152	0.00479	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—pancreatic cancer	0.00151	0.00477	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CD—pancreatic cancer	0.00151	0.00221	CbGpPWpGaD
Tiludronate—Diarrhoea—Fluorouracil—pancreatic cancer	0.0015	0.00475	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—pancreatic cancer	0.0015	0.00219	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HEY2—pancreatic cancer	0.00146	0.00214	CbGpPWpGaD
Tiludronate—Dizziness—Fluorouracil—pancreatic cancer	0.00145	0.00459	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00144	0.00456	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.00144	0.00211	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.00144	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ZNRF3—pancreatic cancer	0.00144	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ACVR1B—pancreatic cancer	0.00144	0.00211	CbGpPWpGaD
Tiludronate—Headache—Irinotecan—pancreatic cancer	0.00144	0.00454	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—pancreatic cancer	0.00141	0.00207	CbGpPWpGaD
Tiludronate—Headache—Gemcitabine—pancreatic cancer	0.0014	0.00442	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—pancreatic cancer	0.0014	0.00441	CcSEcCtD
Tiludronate—Dyspepsia—Docetaxel—pancreatic cancer	0.0014	0.00441	CcSEcCtD
Tiludronate—Headache—Fluorouracil—pancreatic cancer	0.00138	0.00435	CcSEcCtD
Tiludronate—Nausea—Irinotecan—pancreatic cancer	0.00136	0.0043	CcSEcCtD
Tiludronate—Pain—Docetaxel—pancreatic cancer	0.00136	0.00428	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HEY1—pancreatic cancer	0.00135	0.00198	CbGpPWpGaD
Tiludronate—Nausea—Gemcitabine—pancreatic cancer	0.00133	0.00419	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CB—pancreatic cancer	0.00131	0.00192	CbGpPWpGaD
Tiludronate—Nausea—Fluorouracil—pancreatic cancer	0.0013	0.00412	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—SSTR3—pancreatic cancer	0.0013	0.00191	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—DTX1—pancreatic cancer	0.0013	0.00191	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—DTX1—pancreatic cancer	0.0013	0.00191	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SSTR3—pancreatic cancer	0.0013	0.00191	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0013	0.00409	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.00127	0.00186	CbGpPWpGaD
Tiludronate—Back pain—Epirubicin—pancreatic cancer	0.00127	0.004	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—PIK3CA—pancreatic cancer	0.00125	0.00183	CbGpPWpGaD
Tiludronate—Abdominal pain—Docetaxel—pancreatic cancer	0.00125	0.00396	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—SSTR1—pancreatic cancer	0.00125	0.00183	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SSTR1—pancreatic cancer	0.00125	0.00183	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.00124	0.00181	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPY—pancreatic cancer	0.00123	0.00179	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPY—pancreatic cancer	0.00123	0.00179	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SSTR2—pancreatic cancer	0.0012	0.00176	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SSTR2—pancreatic cancer	0.0012	0.00176	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLAU—pancreatic cancer	0.0012	0.00176	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JAG2—pancreatic cancer	0.0012	0.00175	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MEN1—pancreatic cancer	0.00118	0.00173	CbGpPWpGaD
Tiludronate—Vertigo—Epirubicin—pancreatic cancer	0.00118	0.00372	CcSEcCtD
Tiludronate—ATP6V1A—Disease—SLC2A2—pancreatic cancer	0.00117	0.00172	CbGpPWpGaD
Tiludronate—Back pain—Doxorubicin—pancreatic cancer	0.00117	0.0037	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCKBR—pancreatic cancer	0.00116	0.0017	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCKBR—pancreatic cancer	0.00116	0.0017	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—pancreatic cancer	0.00116	0.0017	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.00114	0.00166	CbGpPWpGaD
Tiludronate—Asthenia—Docetaxel—pancreatic cancer	0.00114	0.00359	CcSEcCtD
Tiludronate—ATP6V1A—Disease—SHH—pancreatic cancer	0.00113	0.00165	CbGpPWpGaD
Tiludronate—Arthralgia—Epirubicin—pancreatic cancer	0.00112	0.00352	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—pancreatic cancer	0.00112	0.00352	CcSEcCtD
Tiludronate—ATP6V1A—Disease—IAPP—pancreatic cancer	0.00111	0.00163	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GLI1—pancreatic cancer	0.00109	0.0016	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—DTX4—pancreatic cancer	0.00109	0.0016	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GLI1—pancreatic cancer	0.00109	0.0016	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—DTX4—pancreatic cancer	0.00109	0.0016	CbGpPWpGaD
Tiludronate—Vertigo—Doxorubicin—pancreatic cancer	0.00109	0.00344	CcSEcCtD
Tiludronate—Diarrhoea—Docetaxel—pancreatic cancer	0.00108	0.00343	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HSPA1B—pancreatic cancer	0.00107	0.00156	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CG—pancreatic cancer	0.00107	0.00156	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRP1—pancreatic cancer	0.00106	0.00155	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00106	0.00155	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRP1—pancreatic cancer	0.00106	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00106	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—EGF—pancreatic cancer	0.00106	0.00154	CbGpPWpGaD
Tiludronate—Dizziness—Docetaxel—pancreatic cancer	0.00105	0.00331	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—pancreatic cancer	0.00103	0.00326	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—pancreatic cancer	0.00103	0.00326	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—AKT1—pancreatic cancer	0.00102	0.0015	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HEY2—pancreatic cancer	0.00102	0.0015	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HEY2—pancreatic cancer	0.00102	0.0015	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—pancreatic cancer	0.00102	0.00149	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NRAS—pancreatic cancer	0.00101	0.00148	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GAST—pancreatic cancer	0.000999	0.00146	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GAST—pancreatic cancer	0.000999	0.00146	CbGpPWpGaD
Tiludronate—Headache—Docetaxel—pancreatic cancer	0.000993	0.00314	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD44—pancreatic cancer	0.000984	0.00144	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000974	0.00308	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.000968	0.00142	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JAG1—pancreatic cancer	0.000956	0.0014	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNA1—pancreatic cancer	0.000953	0.00139	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SCT—pancreatic cancer	0.000947	0.00139	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HEY1—pancreatic cancer	0.000947	0.00139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SCT—pancreatic cancer	0.000947	0.00139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HEY1—pancreatic cancer	0.000947	0.00139	CbGpPWpGaD
Tiludronate—Nausea—Docetaxel—pancreatic cancer	0.000942	0.00297	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—pancreatic cancer	0.000941	0.00297	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—PIK3CD—pancreatic cancer	0.000939	0.00137	CbGpPWpGaD
Tiludronate—Pain—Epirubicin—pancreatic cancer	0.000914	0.00289	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CD44—pancreatic cancer	0.000909	0.00133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCK—pancreatic cancer	0.000903	0.00132	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCK—pancreatic cancer	0.000903	0.00132	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HSPA1A—pancreatic cancer	0.000902	0.00132	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000901	0.00285	CcSEcCtD
Tiludronate—PTPN1—Immune System—IFNA2—pancreatic cancer	0.000887	0.0013	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CNR2—pancreatic cancer	0.00088	0.00129	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GLP1R—pancreatic cancer	0.00088	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CNR2—pancreatic cancer	0.00088	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GLP1R—pancreatic cancer	0.00088	0.00129	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000874	0.00276	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—pancreatic cancer	0.000872	0.00128	CbGpPWpGaD
Tiludronate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000871	0.00275	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000866	0.00127	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCKAR—pancreatic cancer	0.000866	0.00127	CbGpPWpGaD
Tiludronate—Pain—Doxorubicin—pancreatic cancer	0.000846	0.00267	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—pancreatic cancer	0.000845	0.00267	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—JAG2—pancreatic cancer	0.00084	0.00123	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JAG2—pancreatic cancer	0.00084	0.00123	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MEN1—pancreatic cancer	0.000827	0.00121	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MEN1—pancreatic cancer	0.000827	0.00121	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CB—pancreatic cancer	0.000818	0.0012	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000809	0.00256	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—pancreatic cancer	0.000801	0.00117	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000791	0.00116	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SHH—pancreatic cancer	0.000789	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SHH—pancreatic cancer	0.000789	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000784	0.00115	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000784	0.00115	CbGpPWpGaD
Tiludronate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000782	0.00247	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—IAPP—pancreatic cancer	0.00078	0.00114	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IAPP—pancreatic cancer	0.00078	0.00114	CbGpPWpGaD
Tiludronate—Asthenia—Epirubicin—pancreatic cancer	0.000767	0.00242	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000748	0.00109	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000748	0.00109	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTHLH—pancreatic cancer	0.000748	0.00109	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTCH1—pancreatic cancer	0.000748	0.00109	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—pancreatic cancer	0.000741	0.00108	CbGpPWpGaD
Tiludronate—Diarrhoea—Epirubicin—pancreatic cancer	0.000732	0.00231	CcSEcCtD
Tiludronate—ATP6V1A—Disease—SMAD4—pancreatic cancer	0.000717	0.00105	CbGpPWpGaD
Tiludronate—Asthenia—Doxorubicin—pancreatic cancer	0.00071	0.00224	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—pancreatic cancer	0.000707	0.00223	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HES1—pancreatic cancer	0.0007	0.00102	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SST—pancreatic cancer	0.000684	0.001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SST—pancreatic cancer	0.000684	0.001	CbGpPWpGaD
Tiludronate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000677	0.00214	CcSEcCtD
Tiludronate—Headache—Epirubicin—pancreatic cancer	0.00067	0.00212	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—JAG1—pancreatic cancer	0.00067	0.00098	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JAG1—pancreatic cancer	0.00067	0.00098	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000667	0.000976	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000667	0.000976	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—pancreatic cancer	0.000656	0.00096	CbGpPWpGaD
Tiludronate—Dizziness—Doxorubicin—pancreatic cancer	0.000654	0.00207	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—VEGFA—pancreatic cancer	0.000639	0.000935	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—pancreatic cancer	0.000638	0.000934	CbGpPWpGaD
Tiludronate—Nausea—Epirubicin—pancreatic cancer	0.000635	0.00201	CcSEcCtD
Tiludronate—PTPN1—Immune System—TSC2—pancreatic cancer	0.000634	0.000928	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CNR1—pancreatic cancer	0.000632	0.000924	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CNR1—pancreatic cancer	0.000632	0.000924	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NRAS—pancreatic cancer	0.000631	0.000923	CbGpPWpGaD
Tiludronate—Headache—Doxorubicin—pancreatic cancer	0.00062	0.00196	CcSEcCtD
Tiludronate—ATP6V1A—Disease—TERT—pancreatic cancer	0.000614	0.000898	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GCG—pancreatic cancer	0.00061	0.000893	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GCG—pancreatic cancer	0.00061	0.000893	CbGpPWpGaD
Tiludronate—Nausea—Doxorubicin—pancreatic cancer	0.000588	0.00186	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HIF1A—pancreatic cancer	0.000587	0.000859	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—pancreatic cancer	0.000586	0.000858	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TSC2—pancreatic cancer	0.000586	0.000857	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000582	0.000852	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGTR1—pancreatic cancer	0.000582	0.000852	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NFKBIA—pancreatic cancer	0.000578	0.000846	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STK11—pancreatic cancer	0.000574	0.000839	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STK11—pancreatic cancer	0.000574	0.000839	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOE—pancreatic cancer	0.000573	0.000838	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGF—pancreatic cancer	0.000554	0.00081	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—pancreatic cancer	0.000543	0.000795	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOTCH1—pancreatic cancer	0.000529	0.000774	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—pancreatic cancer	0.000515	0.000754	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGF—pancreatic cancer	0.000511	0.000748	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000502	0.000735	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SMAD4—pancreatic cancer	0.000502	0.000735	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—pancreatic cancer	0.000499	0.00073	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—pancreatic cancer	0.000492	0.00072	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HES1—pancreatic cancer	0.000491	0.000718	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HES1—pancreatic cancer	0.000491	0.000718	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—pancreatic cancer	0.000483	0.000706	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—pancreatic cancer	0.000462	0.000675	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—pancreatic cancer	0.000455	0.000665	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—pancreatic cancer	0.00043	0.000629	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—pancreatic cancer	0.00043	0.000629	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—pancreatic cancer	0.000429	0.000628	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000411	0.000601	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—pancreatic cancer	0.000411	0.000601	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TSC2—pancreatic cancer	0.00041	0.0006	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TSC2—pancreatic cancer	0.00041	0.0006	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—pancreatic cancer	0.000408	0.000596	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—pancreatic cancer	0.000401	0.000587	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—pancreatic cancer	0.000401	0.000587	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—pancreatic cancer	0.000396	0.00058	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—pancreatic cancer	0.000393	0.000575	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—pancreatic cancer	0.000393	0.000575	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—pancreatic cancer	0.000393	0.000574	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—pancreatic cancer	0.000381	0.000557	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000374	0.000547	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000374	0.000547	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—pancreatic cancer	0.000371	0.000543	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.00037	0.000542	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH1—pancreatic cancer	0.00037	0.000542	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000362	0.00053	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000362	0.00053	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGF—pancreatic cancer	0.000358	0.000524	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGF—pancreatic cancer	0.000358	0.000524	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CTNNB1—pancreatic cancer	0.000351	0.000514	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—pancreatic cancer	0.000344	0.000503	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—pancreatic cancer	0.000342	0.000501	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—pancreatic cancer	0.000332	0.000485	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NRAS—pancreatic cancer	0.000331	0.000484	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000318	0.000466	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000318	0.000466	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—pancreatic cancer	0.000318	0.000465	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—pancreatic cancer	0.000306	0.000448	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRAS—pancreatic cancer	0.000305	0.000447	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—pancreatic cancer	0.000301	0.000441	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—pancreatic cancer	0.000285	0.000417	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—pancreatic cancer	0.000285	0.000416	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—pancreatic cancer	0.000284	0.000415	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—pancreatic cancer	0.000278	0.000407	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000277	0.000406	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000277	0.000406	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—pancreatic cancer	0.000267	0.00039	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—pancreatic cancer	0.000267	0.00039	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—pancreatic cancer	0.000263	0.000385	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—pancreatic cancer	0.000262	0.000383	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—pancreatic cancer	0.000255	0.000373	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—pancreatic cancer	0.000255	0.000373	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—pancreatic cancer	0.000248	0.000363	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—pancreatic cancer	0.000248	0.000363	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000246	0.00036	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000246	0.00036	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—pancreatic cancer	0.000242	0.000354	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—pancreatic cancer	0.000242	0.000353	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—pancreatic cancer	0.000241	0.000353	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—pancreatic cancer	0.000241	0.000353	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—pancreatic cancer	0.00024	0.000351	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—pancreatic cancer	0.00024	0.000351	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—pancreatic cancer	0.000223	0.000327	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—pancreatic cancer	0.000222	0.000325	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—pancreatic cancer	0.000222	0.000325	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—pancreatic cancer	0.000217	0.000317	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—pancreatic cancer	0.000217	0.000317	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—pancreatic cancer	0.000214	0.000314	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—pancreatic cancer	0.000214	0.000314	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—pancreatic cancer	0.000214	0.000313	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—pancreatic cancer	0.000214	0.000313	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—pancreatic cancer	0.000214	0.000313	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—pancreatic cancer	0.000199	0.000292	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—pancreatic cancer	0.000199	0.000292	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—pancreatic cancer	0.000199	0.000291	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—pancreatic cancer	0.000199	0.000291	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—pancreatic cancer	0.000197	0.000289	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—pancreatic cancer	0.000195	0.000285	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—pancreatic cancer	0.000195	0.000285	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—pancreatic cancer	0.000184	0.000269	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—pancreatic cancer	0.000184	0.000269	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—pancreatic cancer	0.000169	0.000248	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—pancreatic cancer	0.000169	0.000248	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—pancreatic cancer	0.000164	0.000239	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—pancreatic cancer	0.000164	0.000239	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—pancreatic cancer	0.000157	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—pancreatic cancer	0.000157	0.000229	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—pancreatic cancer	0.000138	0.000202	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—pancreatic cancer	0.000138	0.000202	CbGpPWpGaD
